Abstract
ObjectivesTo analyse the perspective of clinical research stakeholders concerning post-trial access to study medication.MethodsQuestionnaires and informed consents were sent through e-mail to 599 ethics committee (EC) members, 290 clinical investigators...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have